News

Industry consortium is poised to manage pharma supply-chain interoperability governance

Chain of identity, chain of custody are high priorities for autologous therapies

Service can be multimodal and multi-provider, and is not device-dependent

Pharma marketing will have to adjust to a new reality

The PBMs’ new trend toward controlling the flow of funds for patient support is raising questions

A laudable goal is being addressed by unusual means, including taxpayer dollars

Former J&J executive will be the organization’s third-ever leader

California researchers needed to find a way to collaborate with their counterparts in Hong Kong

Trump administration goal: ‘substantial quantities of a safe and effective vaccine available for Americans by January 2021’

More packaging vendors are offering ‘curbside recyclable’ containers

Reasons for, and actions to take, when switching hub service providers

Milken Institute survey finds nearly 300 therapies and vaccines

Strains are showing in drug supplies consumed in treating infected patients

Carving out CGTs for payment systems involving government intervention may be an answer

DuPont/Cold Chain Technologies in thermal blankets; va-Q-tec in shipment tracking; big bucks for SkyCell

UPS and CVS Pharmacy collaborate for direct-to-patient delivery; but check out Matternet, UPS’ drone partner

Cellular and genetic therapies (CGTs) are a minor part of commercial business, but a growing part of research activity

Kit Check data show value of track-and-trace technology, especially during the Covid-19 pandemic

Revenue leakage in contracting and sales execution affects 95% of respondents

Acquisition of Cumberland Life Sciences boosts its client base and range of services

Service providers are resetting their business practices to cope with the pandemic

Hub service providers look to telehealth to expand patient connectivity

Commercial teams can prepare for overcoming predictable hurdles

Production quotas for controlled substances are being raised by 15%

Now a Danaher Corp. asset, the former GE Healthcare Life Sciences business has been reshuffled

Newly initiated trials may prove value—but even then, supplies may be limited, and hoarding is already occurring

When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies

For sessions with co-workers or clients, consider these recommendations